HDAC9 and Huntington disease: These results were consistent with previous studies, in which HDAC inhibitors, such as SAHA [9] and butyrate [9], had been shown to reverse the hypoacetylation of histones H3, H4 in vitro and rescue polyQ-induced pathological effects in Drosophila models of HD.